Lindong Weng

Lindong Weng serves as the Director of Pre-Pivotal Biologics Formulation & Process Development at Gilead Sciences since September 2025. Previously, Weng held the position of Associate Director - Cryopreservation at Novo Nordisk from April 2023 to August 2025, leading a multicultural team in developing advanced cryopreservation strategies for cell therapy. Prior to that, Weng was the Director of Cell Therapy Drug Product Process Development at Sana Biotechnology, overseeing drug product process development for CAR T and stem cell-derived therapies. Weng's earlier experience includes roles as a Lead Microfluidics Engineer at enEvolv and a Postdoctoral Scholar at the Broad Institute of MIT and Harvard, contributing to innovations in microfluidic devices and cryopreservation techniques. Weng holds an MBA from the University of Illinois Urbana-Champaign and a Ph.D. in Refrigeration and Cryogenics Engineering from Dalian University of Technology.